PetMed Express, Inc. (NASDAQ:PETS) Plans Quarterly Dividend of $0.28

PetMed Express, Inc. (NASDAQ:PETS) declared a quarterly dividend on Tuesday, October 27th, Wall Street Journal reports. Shareholders of record on Monday, November 9th will be given a dividend of 0.28 per share on Friday, November 20th. This represents a $1.12 annualized dividend and a yield of 3.70%. The ex-dividend date is Friday, November 6th.

PetMed Express has increased its dividend payment by 44.0% over the last three years.

NASDAQ PETS opened at $30.28 on Thursday. PetMed Express has a twelve month low of $21.20 and a twelve month high of $42.88. The stock has a market cap of $613.84 million, a price-to-earnings ratio of 21.48 and a beta of 0.70. The firm’s 50 day moving average price is $30.79 and its two-hundred day moving average price is $33.59.

PetMed Express (NASDAQ:PETS) last posted its quarterly earnings data on Saturday, October 31st. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.02. PetMed Express had a net margin of 9.41% and a return on equity of 21.91%. The firm had revenue of $75.40 million for the quarter, compared to analysts’ expectations of $77.05 million. During the same period in the previous year, the company posted $0.33 EPS. The company’s quarterly revenue was up 7.9% compared to the same quarter last year.

Several equities analysts have recently commented on PETS shares. ValuEngine upgraded shares of PetMed Express from a “sell” rating to a “hold” rating in a report on Wednesday. Sidoti upgraded shares of PetMed Express from a “neutral” rating to a “buy” rating and boosted their price target for the company from $37.00 to $41.00 in a report on Wednesday, August 19th. Finally, BidaskClub cut shares of PetMed Express from a “buy” rating to a “hold” rating in a report on Wednesday, October 21st.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Featured Article: Why are gap-down stocks important?

Dividend History for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with's FREE daily email newsletter.